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Abstract
Upon arrival at their synaptic targets, axons slow down their growth and extensively remodel
before the assembly of presynaptic boutons. Wnt proteins are target-derived secreted fac-
tors that promote axonal remodelling and synaptic assembly. In the developing spinal cord,
Wnts secreted by motor neurons promote axonal remodelling of NT-3 responsive dorsal
root ganglia neurons. Axon remodelling induced by Wnts is characterised by growth cone
pausing and enlargement, processes that depend on the re-organisation of microtubules.
However, the contribution of the actin cytoskeleton has remained unexplored. Here, we
demonstrate that Wnt3a regulates the actin cytoskeleton by rapidly inducing F-actin accu-
mulation in growth cones from rodent DRG neurons through the scaffold protein Dishev-
elled-1 (Dvl1) and the serine-threonine kinase Gsk3β. Importantly, these changes in actin
cytoskeleton occurs before enlargement of the growth cones is evident. Time-lapse imaging
shows that Wnt3a increases lamellar protrusion and filopodia velocity. In addition, pharma-
cological inhibition of actin assembly demonstrates that Wnt3a increases actin dynamics.
Through a yeast-two hybrid screen, we identified the actin-binding protein Eps8 as a direct
interactor of Dvl1, a scaffold protein crucial for the Wnt signalling pathway. Gain of function
of Eps8 mimics Wnt-mediated axon remodelling, whereas Eps8 silencing blocks the axon
remodelling activity of Wnt3a. Importantly, blockade of the Dvl1-Eps8 interaction completely
abolishes Wnt3a-mediated axonal remodelling. These findings demonstrate a novel role for
Wnt-Dvl1 signalling through Eps8 in the regulation of axonal remodeling.
Introduction
The arrival of axons at their synaptic targets results in extensive remodelling of the growth
cone and the terminal portions of the axon leading to the formation of terminal branches and
presynaptic boutons. This extensive remodelling is crucial for the formation of synaptic bou-
tons and requires coordinated changes in the organisation and dynamics of both the actin and
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microtubule cytoskeletons [1–5]. Target-derived cues promote terminal remodelling of axons,
but little is known about how these extracellular signals influence the cytoskeleton.
Wnt secreted molecules play important roles in the formation of neuronal circuits by regu-
lating axon pathfinding and remodelling, dendritic development and synapse assembly [6–11].
Wnts act as target-derived signalling molecules that promote axon terminal remodelling and
the subsequent assembly of presynaptic boutons [12–14]. In the cerebellum, Wnt7a released by
granule cell neurons acts on incoming mossy fiber axons to induce growth cone enlargement
and axonal spreading, processes that are accompanied by the recruitment of presynaptic com-
ponents [12]. Importantly, Wnt7a deficient mice exhibit defects in axonal terminal remodelling
and the accumulation of synaptic proteins at mossy fibre axons [12,15]. In the fly neuromuscu-
lar junction (NMJ), Wg, another member of the Wnt family, is required for the proper forma-
tion of synaptic boutons [16]. In the spinal cord, motorneuron-derived Wnt3 promotes the
axonal terminal remodelling of NT-3 responsive dorsal root ganglia (DRG) neurons [13].
Therefore, Wnt proteins are target-derived signals that induce extensive structural remodelling
of presynaptic axonal terminals.
During axon remodelling, Wnts induce profound changes in the organisation of microtu-
bules (MTs). In the presence of Wnts, MTs extend towards the leading edge of the growth
cone, but their direction is severely affected resulting in the formation of looped MTs [12,14].
Wnt3a acts through a divergent canonical β-catenin pathway that is independent of transcrip-
tion, but requires Dishevelled-1 (Dvl1) and Glycogen synthase kinase 3β (Gsk3β) inhibition to
regulate MT looping [14]. This pathway directly signals to the cytoskeleton by inducing loss of
APC from the MT plus-ends, resulting in defects in the directionality of MT growth [14].
Importantly, studies at the Drosophila NMJ revealed that the divergent canonical Wnt pathway
through Shaggy/Gsk3 promotes axonal remodelling manifested by the formation of satellite
boutons and the presence of looped microtubules [17,18]. Consistently, wgmutants have
defects in synaptic bouton formation and morphology [16,18]. Together, these studies demon-
strate that Wnt signalling factors target the microtubule cytoskeleton to drive axons to their
synaptic targets. However, the effects of Wnts on axonal morphology, such as axonal spreading
and growth cone enlargement, suggest that Wnts might also modulate the actin cytoskeleton.
The actin cytoskeleton is regulated by a number of actin-binding proteins (ABPs) that con-
trol nucleation, severing, cross-linking, and capping of actin filaments, as well as monomer
sequestering. Although a large number of ABPs are present at growth cones, only few have
been examined in axon guidance and target recognition [2,4,19,20]. Eps8 (epidermal growth
factor receptor pathway substrate 8) is a multi-functional actin-binding protein that regulates
the actin cytoskeleton through diverse mechanisms [21–24]. Eps8 binds to filamentous actin
and directly modulates actin dynamics through its barbed-end capping and bundling activities
[22,25]. Eps8 can also regulate the actin cytoskeleton indirectly via tyrosine receptor-mediated
Rac1 activation [24,26,27]. Therefore, Eps8 modulates both actin dynamics and organisation.
In neurons, Eps8 is prominently enriched in axonal growth cones and dendritic spines where it
regulates filopodium and spine formation through its capping activity [28–30]. However, its
role on axonal terminal remodelling remains elusive.
Here, we examined the mechanism by whichWnt signalling regulates the actin cytoskeleton
during terminal axon remodelling. We show that Wnt3a causes a rapid accumulation of F-actin
in growth cones. Time-lapse recordings of neurons expressing GFP-actin revealed that Wnt3a
promotes lamellar protrusion and enhances filopodia movement speed in growth cones, pro-
cesses that are both mediated by increased actin dynamics. In addition, we show that expression
of Dvl1 or Gsk3β inhibition mimic the effect of Wnt3a in F-actin accumulation. Using a yeast-
two hybrid screen, we identified Eps8, a multifunctional actin-regulating protein, as a direct
interactor of Dvl1. Gain of function of Eps8 mimics Wnt3a-mediated growth cone remodelling,
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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whereas loss of function of Eps8 impairs Wnt3a-induced axonal remodelling. Importantly, we
show that the interaction of Dvl1 and Eps8 is required for Wnt3a-mediated axon remodelling.
Our studies identify Eps8 as a novel target for Wnt signalling during axonal remodeling.
Results
Wnt3a promotes accumulation of F-actin in growth cones
Our previous studies showed that Wnt3a reduces axonal outgrowth within 20 minutes, but
induces changes in microtubule organisation and growth cone enlargement by 60 minutes
[14]. Thus, Wnt3a affects growth cone behaviour before changes in microtubule organization
are evident. We therefore examine the possible contribution of the actin cytoskeleton to Wnt-
mediated axonal remodelling. Here, we investigated the impact of Wnt3a in DRG neurons on
the accumulation and distribution of filamentous actin (F-actin) (Fig 1A). We found that
Wnt3a significantly increased F-actin levels in growth cones, as determined by the increase in
the area of highly-intense Phalloidin staining (red and white in pseudocolor images; Fig 1A
and 1B). Given the significant effect of Wnt3a on growth cone size, we normalised the area of
F-actin accumulation to growth cone area (% F-actin accumulation) and found that indeed
Wnt3a increases the percentage of F-actin content in growth cones (Fig 1C). We next deter-
mined the time required for Wnt3a to promote F-actin accumulation in growth cones. Time-
course experiments of DRG neurons treated with Wnt3a revealed that the F-actin accumula-
tion in growth cones occurred within 15 minutes (Fig 1D). These findings demonstrate that
Wnt3a rapidly increases the content of F-actin in growth cones before inducing any changes in
growth cone size and microtubule reorganisation [14].
Wnt3a increases actin dynamics during axon remodelling
The effect of Wnt3a on F-actin content could be due to an increase in the rate actin polymerisa-
tion or decrease in actin depolymerisation. To determine which of these processes are regulated
by Wnt3a, we first performed F-actin recovery experiments [31] using Cytochalasin-D
(CytoD), a pharmacological inhibitor of actin subunit assembly at the filament barbed ends
[32,33]. DRG neurons were treated with two different concentrations of CytoD for 20 minutes
to induce actin disassembly, followed by a 30 minutes recovery period in the presence of con-
trol medium or Wnt3a, during which F-actin would be re-assembled (Fig 2A). When neurons
treated with 0.75 μMCytoD were allowed to recover in control media, a 1.5-fold increase in the
intensity of F-actin was observed in growth cones (Fig 2A). However, when neurons recovered
in the presence of Wnt3a a 3-fold increase in the intensity of F-actin was observed in growth
cones (Fig 2A and 2B). Consistently, neurons treated with 1 μMCytoD showed very little
recovery in F-actin intensity when recovered in control growth medium, yet a significant
recovery was observed in the presence of Wnt3a (Fig 2A and 2B). These results demonstrate
that Wnt3a promotes actin filament assembly or polymerization in growth cones.
To determine whether Wnt3a also affects actin dynamics, neurons were first exposed to
control medium or Wnt3a for 2 hours followed by a short exposure to 1 μMCytoD for 2, 4 and
6 mins (Fig 2C). CytoD did not significantly change the area of highly-intense F-actin content
in control-treated growth cones within the first 6 minutes (Fig 2D). However, filopodia started
to disappear and F-actin aggregates begun to form (Fig 2C), as previously reported [34], dem-
onstrating that CytoD was effective. Interestingly, in Wnt3a-treated growth cones CytoD
induced a significant decrease in the area of highly-intense F-actin content within the first 2
minutes of application (Fig 2C and 2D), resulting in a progressive and rapid decline in F-actin
content back to control levels. These results indicate that Wnt3a promotes the assembly of
highly dynamic actin filaments that are quickly dissembled in the presence of CytoD.
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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To gain further insight into the effect of Wnt3a on the actin cytoskeleton, we performed
time-lapse recordings of DRG neurons expressing GFP-β-actin to visualise of the actin cyto-
skeleton in real time. Lamellar protrusion and filopodia velocity were examined in neurons
exposed to control medium or Wnt3a (Fig 3A, S1 Movie and S2 Movie). We observed that
Fig 1. Wnt3a increases F-actin levels in growth cones. (A) Two hours treatment with Wnt3a induces F-actin accumulation in growth cones of DRG
neurons. Pseudocolor images of growth cones labeled with Phalloidin (bottom panels) highlight the differences in F-actin levels betweenWnt3a and control-
treated cells. Two growth cones of similar size are shown for illustrative purposes. Scale bar: 10 μm. (B) The area of growth cones with bright F-actin staining
(red and white in pseudocolor images) is larger in Wnt3a-treated growth cones than in controls. (C) Growth cone area with bright F-actin was normalized to
total growth cone area. (D) Time-course experiments demonstrate that Wnt3a significantly increases F-actin content in growth cones within 15 mins.
*p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.pone.0134976.g001
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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Wnt3a significantly increased the percentage of lamellar perimeter undergoing protrusion in
growth cones compared to controls (Fig 3A–3C, S1 Movie and S2 Movie). In addition, the
speed of filopodia movement was significantly higher in neurons exposed to Wnt3a compared
to controls (control: 0.022 ± 0.0036 μm/sec; Wnt3a: 0.035 ± 0.002 μm/sec, p<0.05). These
results further suggest that Wnt3a promotes actin polymerisation.
Wnt3a modulates axonal actin through Dvl1 and Gsk3β
To determine howWnt3a regulates actin dynamics, we examined the role of Dvl1 and Gsk3β
as these two Wnt signalling components contribute to Wnt-mediated axonal remodelling [14].
Our previous studies showed that Wnt3a failed to induce axon remodelling in Dvl1 mutant
DRG neurons [14]. We therefore performed gain of function experiments to examine in detail
Fig 2. Wnt3a increases actin dynamics in growth cones. (A) DRG neurons were treated different concentrations of with CytoD and then recovered in
control or Wnt3a growth media. Scale bar: 10μm. (B) Quantification shows that F-actin levels are after recovery are significantly higher in the presence of
Wnt3a. Values indicate F-actin levels relative to growth cones fixed immediately after treatment with CytoD (no recovery). (C) Wnt3a treatment induces
accumulation of F-actin in growth cones, which are rapidly dissembled by after short exposure to 1mMCytoD. Scale bar: 10μm. (D) F-actin content in growth
cones does not significantly decrease in control conditions in the presence of CytoD over the period of 6 mins. In contrast, F-actin content is significantly
decreased in Wnt3a-treated growth cones within 2 mins. *p<0.05, **p<0.01, ns: non-significant.
doi:10.1371/journal.pone.0134976.g002
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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the effect of Dvl1 on actin. As we observed with Wnt3a, gain of function of Dvl1 significantly
increased F-actin accumulation in growth cones (Fig 4A, 4B and 4C).
Given the crucial role of Gsk3 in axon remodelling [14], we next examined whether Gsk3β
inhibition promotes accumulation of F-actin like Wnt3a (Fig 4D). We found that a cell-perme-
able peptide inhibitor, that specifically blocks Gsk3β [35], significantly increased F-actin accu-
mulation in growth cones (Fig 4E and 4F) when applied for 2 hrs. To determine whether
Gsk3β inhibition acts on the same time-frame with Wnt3a and whether F-actin accumulation
precedes Gsk3β-mediated growth cone remodelling, we treated DRG neurons with the cell-
permeable Gsk3β peptide inhibitor for 15 mins (Fig 4G). We found that acute inhibition of
Gsk3β did significantly induce F-actin accumulation in growth cones without affecting growth
cone size (Fig 4I and 4H). Together, these results suggest that Wnt3a regulates actin dynamics
through Dvl1 and inhibition of Gsk3β.
Dvl1 interacts with the actin-binding protein Eps8
To further unravel the mechanisms by which Wnt3a regulates the actin cytoskeleton during
axonal remodelling, we performed a yeast two-hybrid screen to identify molecules that interact
with Dvl1 and regulate the actin cytoskeleton. We found that Eps8L3, a member of the Eps8
family of actin-binding proteins, showed a direct interaction with Dvl1 (Fig 5A). Importantly,
this interaction was strong, as revealed by the stringent nutrition selection (lacking Histidine
and Adenine) (Fig 5A). Given the lack of commercial antibodies for Eps8L3, we focused our
studies on Eps8, another member of this family of actin-capping proteins, which is most highly
expressed in the nervous system [23] and has been previously shown to bind Dvl1 [36].
Previous studies showed that Eps8 recruits XDsh (the Xenopus homologue of Dvl1) to the
plasma membrane and actin filaments in animal cap cells [37]. To examine whether Eps8 can
Fig 3. Wnt3a increases lamellar protrusion. (A) Still frames captured 1 min apart from time-lapse
recordings of GFP-β-actin expressing neurons exposed to control or Wnt3a medium for 16 hours. Scale bar:
5μm. (B) Tracings of lamella undergoing protrusion (protruded perimeter depicted in dashed line). (C)
Quantification shows that Wnt3a significantly increases the percentage of lamella undergoing protrusion.
*p<0.05.
doi:10.1371/journal.pone.0134976.g003
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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Fig 4. Dvl1 gain of function and inhibition of Gsk3βmimic the effect of Wnt3a in F-actin accumulation.
(A) Dvl1 gain of function induces F-actin accumulation in growth cones. Pseudocolor images of growth cones
labeled with phalloidin show significant differences in F-actin levels between Dvl1-expressing and control
GFP-expressing cells. Scale bar: 5μm. (B and C) Dvl1 increases the area of growth cones with bright F-actin
staining and also induces the percentage of growth cone area containing high levels of F-actin. (D) A specific
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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affect the localization of Dvl1 in neuronal cells, we co-expressed Eps8 and Dvl1 in differenti-
ated Neuroblastoma 2a (N2a) cells. When expressed alone, Eps8 had a membrane and punctate
localisation (Fig 5B). In contrast, in the presence of Dvl1, Eps8 co-localised with Dvl1 puncta
and its localization to the membrane decreased (Fig 5B). These results suggest that Eps8 might
be recruited to Dvl1 sites. Moreover, co-immunoprecipitation experiments demonstrated that
Gsk3β peptide inhibitor promotes accumulation of F-actin in growth cones. Scale bar: 5μm. (E) Inhibition of
Gsk3β induces F-actin accumulation and (F) the percentage of growth cone area with bright F-actin
fluorescence. (G-H) Acute expose to the Gsk3β peptide inhibitor promotes accumulation of F-actin in growth
cones, without affecting growth cone size. Scale bar: 5μm. *p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.pone.0134976.g004
Fig 5. Dvl1 interacts with the actin-binding protein Eps8. (A) Dvl1 was fused to the GAL4 DNA binding
domain (BD) and tested for interactions against an empty vector or Eps8L3 fused to the GAL4 activation
domain (AD). Growth on-His and-His/-Ade media shows a strong and direct interaction of Dvl1 with Eps8L3,
but not with the empty vector (AD). (B) The presence of Dvl1 changes the cellular localisation of Eps8 into
defined puncta also containing Dvl1 in N2a cells. Scale bar: 10μm. (C) Co-immunoprecipitation experiments
show the interaction between Dvl1 and Eps8 in N2a cells. (D) Immunoprecipitation experiments using brain
lysates from P24 mice show that endogenous Eps8 interacts with endogenous Dvl1.
doi:10.1371/journal.pone.0134976.g005
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
PLOS ONE | DOI:10.1371/journal.pone.0134976 August 7, 2015 8 / 19
these proteins interacted in N2a neuronal cells (Fig 5C). Importantly, in the adult mouse brain,
we found an interaction between endogenous Dvl1 and Eps8 using immunoprecipitation (Fig
5D). Collectively, these results demonstrate that Dvl1 interacts with Eps8 in neurons and that
Dvl1 may regulate the distribution and/or function of Eps8.
Eps8 is required for Wnt3a-mediated axonal remodelling
As Eps8 is an actin-binding protein and interacts with Dvl1, this protein could mediate the effect
of Wnt-mediated axon remodelling, in particular the changes in actin cytoskeleton. To examine
this possibility, we first performed gain of function studies and found that Eps8 induced axonal
remodelling manifested by a significant increase in growth cone size when compared to control
GFP-expressing cells (Fig 6A and 6B). We also found that like withWnt3a or gain of function of
Dvl1, Eps8 induced a significant increase in F-actin accumulation (Fig 6A and 6C). Next, we
examined whether Eps8 induces changes in microtubule organisation, as we have previously
shown for the Wnt3a-Dvl1-Gsk3β pathway [14]. In control GFP-expressing DRG neurons,
microtubules had a splay morphology (S2 Fig). However, Eps8-expressing DRG neurons had
enlarged growth cones with looped microtubules (S2 Fig), as observed with exposure toWnt3a,
expression of Dvl1 or inhibition of Gsk3β [14]. Thus, Eps8 mimics the effect of Wnt3a and Dvl1
gain of function on axonal remodelling by affecting both the actin and microtubule cytoskeleton.
Next we performed loss of function studies using shRNA-mediated Eps8 knockdown (Eps8
KD) (Fig 6D). To obtain a significant level of knockdown, DRG neurons were transfected with
a combination of three different shRNAs that specifically target Eps8 [29]. Neurons expressing
scrambled control shRNA construct were used as controls. To first verify that we efficiently
silenced Eps8, we quantified the level of endogenous Eps8 in growth cones and found that
expression of Eps8 shRNAs promoted a significant reduction in Eps8 protein levels (S3 Fig). In
addition, we analysed the number of axonal filopodia, as previous studies have shown that loss
of Eps8 results in increased filopodium density in both axons and dendrites [28,29]. Indeed, we
observed that cells expressing shRNAs against Eps8 exhibited a 48% increase in axonal filopo-
dium density (S3 Fig), demonstrating a significant loss of function effect of Eps8 [28,29]. We
then examined the impact of Eps8 loss of function onWnt3a-induced growth cone remodel-
ling. We found that Wnt3a induced axonal remodelling in control “scrambled” shRNA-
expressing cells by increasing both the percentage of cells that showed enlarged growth cones
(% of cells remodelled; Fig 6E) and the average growth cone area (Fig 6F), as we have previ-
ously shown [14]. In contrast, Eps8 shRNA-expressing neurons did not remodel in the pres-
ence of Wnt3a (Fig 6D–6F). These experiments demonstrate that Eps8 is required for Wnt3a
signalling to induce axonal remodelling.
To determine the role of the interaction of Dvl1 and Eps8 in Wnt3a-mediated axonal
remodelling, we decided to interfere with the binding between these two proteins. A previous
study showed that Eps8 interacts with the PDZ domain of Dvl1 [36], a conserved region
important for protein-protein interactions and for Wnt signalling [38–42]. We therefore
decided to examine the contribution of the PDZ domain of Dvl1 to Eps8 function.
First, we co-expressed Eps8 and a mutant Dvl1 that lacks the PDZ domain (Dvl1ΔPDZ) in
differentiated N2a cells. We found that Dvl1ΔPDZ was not able to change the localisation of
Eps8 (Fig 7A), in sharp contrast to full length Dvl1 (Fig 5B). These results suggest that the
redistribution of Eps8 by Dvl1 depends on the PDZ domain of Dvl1. Next, we reasoned that
the PDZ domain of Dvl1 could block Dvl1-Eps8 interaction and therefore interfere with its
function in Wnt-mediated remodelling. To examine this, we co-expressed full length Eps8,
Dvl1 with the PDZ domain of Dvl1 in N2a cells and performed co-immunoprecipitation exper-
iments. We found that the PDZ domain substantially decreased the interaction between Eps8
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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Fig 6. Eps8 is required for Wnt3a-mediated axonal remodeling. (A) Eps8 promotes growth cone
enlargement and increases F-actin accumulation in growth cones. Pseudocolor images show the different
levels of F-actin in growth cones of Eps8-expressing and control GFP-expressing cells. Scale bar: 5μm. (B
and C) Growth cone area is larger in Eps8-expressing cells than in controls cells, as is the percentage of
growth cone area with high F-actin fluorescence. (D) DRG neurons expressing scramble or Eps8 shRNAs
were treated with Wnt3a for 2 hrs. Scale bar: 5μm. (E) In scrambled shRNA-expressing cells Wnt3a
increases the percentage of cells that show axonal remodelling (% of cells remodelled) and (F) promotes
growth cone enlargement. In contrast, neurons expressing Eps8shRNAs do not respond to Wnt3a. *p<0.05,
**p<0.01, ***p<0.001.
doi:10.1371/journal.pone.0134976.g006
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and Dvl1 (Fig 7B). Thus, the PDZ domain of Dvl1 could be used as a tool to examine the role
of Dvl1-Eps8 interaction in axonal remodelling.
Next, we investigated the contribution of the interaction of Dvl1 with Eps8 onWnt-medi-
ated axon remodelling. We found that DRG neurons expressing the PDZ domain of Dvl1 were
Fig 7. The interaction between Dvl1 and Eps8 is required for Wnt3a-mediated axonal remodeling. (A)
Dvl1ΔPDZ does not affect the localisation of Eps8 in N2a cells. (B) Expression of the PDZ domain of Dvl1 in
N2a cells decreases the binding of Dvl1 and Eps8 by 38%, as assessed by co-immunoprecipitation
experiments. (C) DRG neurons expressing the PDZ domain of Dvl1 were treated with Wnt3a for 2 hrs. Scale
bar: 5μm. (D) In GFP-expressing cells Wnt3a increases the percentage of cells that show axonal remodelling
(% of cells remodelled). In contrast, neurons expressing the PDZ domain of Dvl1 do not remodel in the
presence of Wnt3a. (E) Proposed model for the role of Eps8 in Wnt3a-mediated axonal remodelling. Wnt3/3a
induces the formation of highly dynamic actin filaments and growth cone enlargement. These effects are
mediated though the direct interaction of Dvl1 and Eps8, and Gsk3β inhibition possibly induced by Eps8-Akt
signalling. *p<0.05.
doi:10.1371/journal.pone.0134976.g007
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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unable to respond to Wnt3a, in contrast to control neurons that showed enlarged growth cones
upon exposure to Wnt3a (% of cells remodelled; Fig 7C and 7D). These findings demonstrate
that the interaction between Dvl1 and Eps8 is required for growth cone remodelling induced
by Wnt3a.
Discussion
Here we demonstrate that Wnt signalling promotes axon remodelling, a process that precedes
the formation of synaptic boutons, by controlling the dynamics of the actin cytoskeleton in
addition to its previous described role in microtubule re-organisation. Our previous studies
showed that Wnt3a induces axonal remodelling through changes in the organisation and
dynamics of microtubules [13,14]. In this study, we now show that Wnt3a also promotes pro-
found changes in the actin cytoskeleton during axon remodelling through a pathway that
involves the scaffold protein Dvl1, Eps8, an actin-binding protein that directly interacts with
Dvl1, and inhibition of Gsk3β. Importantly, Eps8 and its interaction with Dvl1 is required for
Wnt3a-mediated axonal remodelling. These findings reveal a novel role for Eps8 downstream
of Wnt signalling to regulate cytoskeleton remodelling.
During axon remodelling, Wnt3a induces growth cone pausing within the first 20 minutes
accompanied by an increase in membrane protrusion in growth cones and at the distal portion
of the axon [14]. This effect is followed by the loss of APC from microtubule plus ends at 30
mins, growth cone enlargement and the formation of looped microtubules. Although, growth
cones start to increase in size after 30 mins, the full effect of Wnts on growth cone enlargement
is evident after 60 mins [14]. Here we showed that Wnt3a also promoted accumulation of F-
actin in growth cones within 15 minutes and therefore before the time when MTs or growth
cone size are affected. Interestingly, we have previously shown that blocking actin dynamics
with low levels of Latrunculin B does not fully impair Wnt3a-mediated growth cone remodel-
ling [14]. This result originally indicated that actin dynamics is not critical for Wnt3a-mediated
remodelling. However, our new findings clearly demonstrated that Wnt3a induced profound
changes in the actin cytoskeleton prior to growth cone remodelling, suggesting that actin
dynamics is also important for Wnt3a-mediated axonal remodelling. These apparent contra-
dictory results could be explained by the fact that Latrunculin B binds to and sequesters actin
monomers in a molar ratio of 1:1 [43]. If used at low concentration, Latrunculin B will only
affect a small fraction of the actin monomer pool present at growth cones. Thus, Wnt3a could
still induce F-actin accumulation and changes in actin dynamics by targeting the remaining
monomers of actin that have not been sequestered by Latrunculin B.
How is actin dynamics modulated during axon remodelling? Actin dynamics is important for
proper axonal extension and axon guidance. Attractive molecules increase actin polymerisation
and the levels of F-actin in growth cones within minutes, whereas repulsive guidance cues have
the opposite effect [4,44–46]. During axon remodelling, however, the changes in the actin cyto-
skeleton are not well understood. Our time-lapse recordings of neurons expressing GFP-actin
revealed that Wnt3a increased lamellar protrusion and filopodial velocity. Moreover, F-actin
recovery experiments after depolymerisation with CytoD demonstrated that actin filaments poly-
merised faster in the presence ofWnt3a. Interestingly, short exposure to CytoD rapidly depoly-
merised accumulated F-actin inWnt3a treated growth cones, but not in controls. Together these
results indicate that Wnt3a induces the formation of highly dynamic actin filaments.
Wnts signal through a divergent Wnt canonical pathway to regulate the cytoskeleton during
axon remodelling. Our previous studies have shown that Wnt3a through Dvl1 and inhibition
of Gsk3β, but not transcription induces changes in the microtubule cytoskeleton during
remodelling [14]. Similarly axon remodelling at the Drosophila NMJ has shown that Wg
Eps8 Is Required for Wnt3a-Mediated Axonal Remodelling
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promotes microtubule reorganization at synaptic boutons through a pathway that requires
Shaggy/Gsk3, but is transcription-independent [18]. Here we showed that Wnt3a signalling
through Dvl1 and inhibition of Gsk3β was also involved in regulating the actin cytoskeleton.
Thus, activation of a Wnt divergent canonical pathway is responsible for both actin and micro-
tubule cytoskeletal changes during axon terminal remodelling.
Actin-binding proteins play a crucial role in the regulation of actin dynamics and organisa-
tion. Among the actin binding proteins is Eps8, a multi-functional protein that regulates the
actin cytoskeleton through direct and indirect mechanisms [21,22,24,47]. Here we demonstrate
that Eps8, which directly interacts with Dvl1 (this study and [36]), promotes growth cone
enlargement, accumulation of F-actin and microtubule looping in growth cones, thus mimick-
ing Wnt signalling in axon remodelling. Importantly, loss of function of Eps8 or interference of
its interaction with Dvl1 blocks the ability of Wnt3a to induce axonal remodelling. How does
Eps8 induce axonal remodelling? Previous studies showed that Eps8 acts as a capping protein
to regulate filopodium and spine formation in hippocampal neurons [28–30]. Consistent with
these findings, we found that Eps8 loss of function increased axonal filopodium density in
DRG neurons. These results suggest that Eps8 could promote axonal remodelling through its
actin capping activity. However, high capping activity would lead to a decrease in F-actin con-
tent [21,29,48] rather than an increase, as we observed in our Eps8 gain of function studies.
These findings suggest that Eps8 induces axonal remodelling independently of its actin-cap-
ping activity. Eps8 has also been shown to confer actin bundling activity, resulting in excessive
filopodium formation and membrane extension in heterologous cells [22,49]. In contrast, our
gain of function experiments showed that Eps8 did not increase the number or the length of
filopodia in growth cones (S4 Fig). Together these results suggest that Eps8 promotes terminal
remodelling of axons through a mechanism independent of its capping or bundling activities.
How does Eps8 contribute to Wnt-mediated remodelling? Here we demonstrate that Dvl1,
a molecular hub for Wnt signalling, directly interacts with Eps8. Importantly interfering with
the interaction blocks Wnt-mediated remodelling. This interaction is through the PDZ
domain, which is crucial for canonical Wnt-Gsk3β signalling [38–42], Interestingly, Eps8 has
been shown to activate Akt, a kinase that phosphorylates and inactivates Gsk3β [50,51].
Indeed, Eps8 enhances cell proliferation and migration through the PI3K-Akt pathway and
increases β-catenin levels [52–54]. Importantly, expression of a constitutively active form of
Akt in DRG neurons increases branching and growth cone size [55], mimicking the effects
observed upon activation of the Wnt3a-Dvl1-Gsk3β pathway [14]. These findings raise the
possibility that Wnt3a regulates axonal remodelling through a pathway in which the interac-
tion of Eps8 with Dvl1 activates Akt, leading to Gsk3β inhibition and resulting in growth cone
enlargement and axon remodelling (Fig 7E).
In summary, our studies demonstrate that Wnt3a signalling, through the scaffold protein
Dvl1 and inhibition of Gsk3β, promotes axon remodelling through changes in actin dynamics
followed by changes in the microtubule cytoskeleton. Wnt3a-induced axonal remodelling is
mediated by the actin-binding protein Eps8 through its direct interaction with Dvl1. Our stud-
ies reveal Eps8 as a novel target of Wnt signalling and demonstrate a role for Eps8 in axon ter-
minal remodelling.
Materials and Methods
Cultured neurons
All experiments that included animals were carried out under personal and project licenses
granted by the UK Home Office in accordance with the Animals (Scientific Procedures) Act
1986. All animal protocols were approved by the UK Home Office and the University College
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London Ethical Review Committee. Efforts were made to minimize animal suffering. DRG
neurons were isolated from newborn mice or E18 rat embryos according to Kleitman et al.
(1991) and plated at 180 cells/mm2 on coverslips coated with 1 mg/mL poly-L-lysine (Sigma)
and 20 μg/mL Laminin (Sigma). Neurons were cultured in serum-free medium in the presence
of 50 μg/mL NGF (Invitrogen). Two hours after plating neurons were treated with conditioned
medium from control or Wnt3-HA expressing Rat1B cells or with 50 ng/mL of purified Wnt3a
(R&D) or for two hours with 2μMGsk3β cell-permeable peptide inhibitor (Calbiochem). For
transfections, DRG neurons were electroporated using Amaxa nucleofection (Lonza) according
to the manufacture’s instructions. Briefly, dissociated DRGs were centrifuged at 110g for 5
mins and re-suspended in the appropriate nucleofector solution containing 5–10 μg of DNA.
Different DNA constructs were used: EGFP, GFP-β-actin, Dvl1-HA, Eps8-myc, scrambled
shRNA and a cocktail of 3 shRNAs against Eps8 [29].
Neuroblastoma 2a (N2a) cells
N2a cells (Sigma) were cultured in DMEMmedium with Glutamax supplemented with 10%
FBS and 1% v/v Pen/Strep. For transfections, cells were plated at 400 cells/mm2 and the follow-
ing day were transfected using Lipofectamine 2000 (invitrogen), according to the manufac-
ture’s instructions. Three hours after transfection, the medium was replaced with fresh
Optimem medium and 2 hrs after 1 μM dibutyryl-cyclic-AMP (Sigma) was added to induce
differentiation.
Time-lapse recordings
DRG neurons were transfected with GFP-β-actin and treated with control or Wnt3a media two
hours later. Time-lapse experiments were performed the following day on an inverted Axiovert
Zeiss 200 microscope equipped with a heated stage and CO2 chamber. Recordings were three
to five minutes long with a 20 seconds interval. Images were collected and analyzed using
Metamorph software (Molecular Devices). Filopodia movement speed was determined by
tracking their tips over consecutive frames, whereas the relative percentage of lamellar perime-
ter undergoing protrusion was quantified from time-lapse frames captured 1 min apart.
Immunoprecipitation (IP)
N2a cells or spinal cord tissue were lysed in Triton buffer (50 mMHepes, 100 mMNaCl, 4 mM
EGTA, 2 mMMgCl2, 0.5% v/v TritonX100, pH 7.4) supplemented with 1 mM PMSF, 1 mM
Na3VO4, 10 μg/mL leupeptin, 10 μg/mL aprotinin, 25 mMNaF and 1 μM pepstatin. Lysates
were pre-cleared for 2 hours at 4°C (10 rpm) using G- or A- protein Sepharose beads. The pre-
cleared lysates were then incubated overnight at 4°C (10 rpm) with specific anti-myc (Sigma) or
anti-Dvl1 [13] antibodies or an anti-IgG cocktail (Biorad). The following day G- or A- protein
Sepharose beads were added for 2 hours and subsequently centrifuged and washed 3 times with
Triton buffer. Proteins bound on beads were extracted with equal volume of 2x SDS loading
buffer (120 mM Tris, 100 mMDTT, 1.6 g/mL SDS, 0.4 g/mL bromophenol blue, 20% v/v glyc-
erol, pH 6.8). Bead extracts were loaded on SDS/PAGE and antibodies against Dvl1 [13] (rabbit
polyclonal, dilution 1:1000) or Eps8 (BD, mouse monoclonal, dilution 1:500) were used.
Cloning
Dvl1 full-length cDNA was isolated by PCR and then cloned into the pGBDT7 vector using the
EcoRI and SalI sites to create a GAL4 DNA binding domain (BD) Dvl1 fusion. Primers used
were Fwd: 5’–CGTACAGAATTCGCGG AGACCAAAATCAT –3’ and Rvs: 5’–GGCTAGTCGA
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CCATGATGTCCAC AAAG –3’. Eps8L3 full-length cDNA was isolated by PCR using cDNA
made from P24 mouse brain and was then cloned onto the pGADT7 vector using the ClaI and
XhoI sites to create a GAL4 activation domain (AD) fusion. Primers used were Fwd: 5’–
AAGCTACTCGAGCTAATGAGTCATCCCCAGCATCCT –3’ and Rvs: 5’–AAGTACATCGAT
ATGTCCCGGCCCAGCAGCA GAGCCAT –3’. Eps8-myc cloned into the PCS2+ was a kind gift
from Dr J. Miller (University of Minnesota, Minneapolis). To create the Eps8Δ533–821 the
Eps8-myc was used as a template for a PCR reaction, Fwd: 5’–AAGTACATCGATATGAATGG
TCATATGTCTAACCGC– 3’ and Rvs: 5’–AAGTACCTCGAGTCATAGGT CTTCGGAGATT
AGCTTTTGCTCG– 3’. The PCR product was inserted into PCS2+ using the ClaI and XhoI
sites. The cloning of the Dvl1ΔPDZ has been previously described in [56]. To clone the PDZ
domain of Dvl1 (amino acids 278–337) the mouse Dvl1 cDNA was used as a template for a
PCR reaction, Fwd: 5’–CGTACAGAATTCATGATCTACATTGGATCCATCAT– 3’ and Rvs:
5’–GCTATACTCGAGTCAAGCGTAATCTGGAACATCGTACTTGGCCTCTGTGA GACTGAT–
3’. The PCR product was inserted into PCS2+ using the EcoRI and XhoI sites. All constructs
were verified by DNA sequencing.
Yeast two hybrid screen and assays
To perform the yeast two hybrid screen the AH109 yeast strain (MATa), transformed with the
GAL4 DNA binding domain (BD) Dvl1 fusion, was mated with the Y187 strain (MATα),
transformed with a cDNA library isolated from adult mouse brain (Clonetech), according to
the manufacture’s instructions. For the yeast two hybrid assays empty pGBKT7 and GAL4
DNA binding domain (BD) Dvl1 fusion were transformed into the yeast strain AH109
(MATa), whereas the empty pGADT7 and Eps8L3-GAL4 activation domain (AD) fusion were
transformed into the Y187 strain (MATα). Two yeast transformants for each plasmid combi-
nation were mated on rich YPDA medium and selected under nutrition restriction on plates
containing synthetic media without Leucine and Tryptophan (Clontech). Protein interactions
were then assayed by monitoring growth on synthetic media lacking Histidine or Histidine and
Adenine (Clontech).
Immunofluorescence microscopy and analyses
Cultures were fixed with 4% PFA / 4% sucrose in PBS for 20 mins at room temperature. Pri-
mary antibodies against HA (Roche, rat monoclonal, dilution 1:1000), GFP (Upstate, chicken
polyclonal, dilution 1:500), Myc (Sigma, rabbit polyclonal, dilution 1:2000) were used. Second-
ary antibodies conjugated with Alexa 488, Alexa 568, Alexa 647 and Phalloidin conjugated
with Alexa 647 were fromMolecular Probes. Fluorescent images of growth cones from
NT3-rensponsive neurons were captured using an Olympus BX60 wide-field microscope with
a 100x oil objective (NA = 1.30). At least 50 growth cones were analysed per condition using
the Metamorph software (Molecular Devices). Growth cone size was determined from the
growth cone area, measured manually using the drawing tool. Accumulation of F-actin was
determined by setting a high threshold on the Phalloidin images (red and white area in pseudo-
color images).
Statistical analyses
Values given are mean ± standard error. Values given are mean ± error. Data presented is the
pool from at least three independent experiments. For datasets with normal distribution, an
ANOVA test was used. For datasets that were not normally distributed, the Kruskal-Wallis test
was used.
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Supporting Information
S1 Fig. Dvl1 overexpression in DRG growth cones.HA expression in growth cones presented
in Fig 4A. Scale bar: 5 μm.
(EPS)
S2 Fig. Eps8 gain of function induces the formation of looped microtubules in growth
cones. (A) Myc expression in growth cones presented in Fig 6A. (B) Eps8 expressing DRG neu-
rons possess enlarged growth cones with looped microtubules.
(EPS)
S3 Fig. Loss of function of Eps8 induces filopodium formation in axons. (A and B) Expres-
sion of Eps8 shRNAs significantly reduces the levels of endogenous Eps8 in growth cones.
Scale bar: 5 μm. (C and D) Eps8 KD significantly increases the number of axonal filopodia.
Scale bar: 2 μm. p<0.01.
(EPS)
S4 Fig. Eps8 does not promote filopodium formation in growth cones. (A and B) Eps8 gain
of function does not increase the length or the number of filopodia in growth cones. p<0.05.
(EPS)
S5 Fig. Original blots from IP experiments. (A) Blot presented in Fig 5C. (B) Blot presented
in Fig 5D. (C) Blots from Fig 7B. Molecular size for ladder bands (From top to bottom):
175kDa, 80kDa, 58kDa, 46kDa, 30kDa and 23kDa.
(EPS)
S1 Movie. Time-lapse recording of a growth cone expressing GFP-actin treated with con-
trol growth medium. A GFP-actin expressing growth cone from control-treated DRG neurons
was recorded for 3 mins with a frame interval of 20 seconds. The perimeter of lamella undergo-
ing protrusion and filopodium velocity was quantified (% lamellar protrusion: 19.58 ± 2.99;
filopodium velocity: 0.031 ± 0.001 μm/sec).
(MOV)
S2 Movie. Time-lapse recording of a growth cone expressing GFP-actin treated with Wnt3a
growth medium. A GFP-actin expressing growth cone fromWnt3a-treated DRG neurons was
recorded for 3 mins with a frame interval of 20 seconds. The perimeter of lamella undergoing
protrusion and filopodium velocity was quantified (% lamellar protrusion: 32.77 ± 1.15; filopo-
dium velocity: 0.057 ± 0.008 μm/sec).
(MOV)
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